TLOG (TetraLogic Pharmaceuticals) Interest Expense: $-6.80 Mil (TTM As of Sep. 2016)

What is TetraLogic Pharmaceuticals Interest Expense?

TetraLogic Pharmaceuticals TLOG Interest Expense is $-6.80 Mil as of Sep. 2016.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TetraLogic Pharmaceuticals's interest expense for the three months ended in Sep. 2016 was $ -1.76 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2016 was $-6.80 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TetraLogic Pharmaceuticals's Operating Income for the three months ended in Sep. 2016 was $ -3.76 Mil. TetraLogic Pharmaceuticals's Interest Expense for the three months ended in Sep. 2016 was $ -1.76 Mil. TetraLogic Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TetraLogic Pharmaceuticals (OTCPK:TLOG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TetraLogic Pharmaceuticals's Interest Expense for the three months ended in Sep. 2016 was $-1.76 Mil. Its Operating Income for the three months ended in Sep. 2016 was $-3.76 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2016 was $30.81 Mil.

TetraLogic Pharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2016 is calculated as

TetraLogic Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

TetraLogic Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Interest Expense can be seen below:

TetraLogic Pharmaceuticals Interest Expense Chart

TetraLogic Pharmaceuticals Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Interest Expense

-0.01

-0.07

-2.77

-3.36

-6.38

TetraLogic Pharmaceuticals Quarterly Data
	Dec11	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Interest Expense	Get a 7-Day Free Trial													-1.61	-1.64	-1.68	-1.72	-1.76

TetraLogic Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.80 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-6.80 Mil mean?

TetraLogic Pharmaceuticals (TLOG) has a Interest Expense of $-6.80 Mil as of Sep. 2016. Interest Expense is the amount a company pays on its long-term debt. View historical data on TetraLogic Pharmaceuticals and its competitors.

Is TetraLogic Pharmaceuticals' Interest Expense too high?

TetraLogic Pharmaceuticals' current Interest Expense is $-6.80 Mil.

How does TetraLogic Pharmaceuticals' Interest Expense compare to ARGSQ and GTHR?

TetraLogic Pharmaceuticals' Interest Expense of $-6.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Interest Expense is $-6.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is TetraLogic Pharmaceuticals stock overvalued right now?

TetraLogic Pharmaceuticals (TLOG) has a current Interest Expense of $-6.80 Mil. The current Interest Expense is $-6.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Interest Expense is $-6.80 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ARGSQ GTHR SOAN CTBO BOM:524604 GWSN WAR:PFM TSXV:PBS IMUC MBVXQ NTRR STLT XSAT:EURI B HSTC BOM:506365 BOM:532041 ATMS BOM:524796 LSE:ANIC TSXV:COT

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355

Website http://www.tetralogicpharma.com

TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.